Renata PLC (DSE:RENATA)
Bangladesh · Delayed Price · Currency is BDT 430.10
0.00 (0.00%)
At close: Mar 24, 2026
Renata Market Cap
Renata has a market cap or net worth of 49.33 billion as of March 24, 2026. Its market cap has decreased by -14.27% in one year.
Market Cap
49.33B
Enterprise Value
66.80B
Revenue
44.26B
Ranking
n/a
PE Ratio
19.45
Stock Price
430.10
Market Cap Chart
Since June 2, 2003, Renata's market cap has increased from 320.77M to 49.33B, an increase of 15,278.84%. That is a compound annual growth rate of 24.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 49.77B | 10.75% |
| Dec 30, 2025 | 44.94B | -38.31% |
| Dec 30, 2024 | 72.84B | -47.85% |
| Dec 27, 2023 | 139.69B | - |
| Dec 29, 2022 | 139.69B | -0.67% |
| Dec 30, 2021 | 140.64B | 30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 192.63B |
| Beximco Pharmaceuticals PLC. | 52.55B |
| Unilever Consumer Care | 42.14B |
| Beacon Pharmaceuticals | 23.54B |
| The ACME Laboratories | 16.55B |
| The IBN SINA Pharmaceutical Industry | 10.03B |
| Asiatic Laboratories | 8.53B |
| Orion Pharma | 6.83B |